Ortega M, de Segura I A, Vázquez I, López J M, De Miguel E
Service of Experimental Surgery, La Paz University Hospital, Madrid, Spain.
Rev Esp Enferm Dig. 2001 Mar;93(3):148-55.
To determine whether exogenously administered growth hormone can reduce or prevent chemotherapy-induced intestinal mucosa injury. The expected results will allow to consider its potential clinical use.
Experimental and randomized study.
Experimental Surgery Service, La Paz University Hospital.
Adult Wistar rats weighing 250-300 g.
A chemotherapy protocol with methotrexate (MTX) (120 mg/kg) was employed. Animals fed either with a normoproteic or a hyperproteic liquid diet were treated with either saline or growth hormone (1 mg/kg/day) since three days before until four days after chemotherapy. Animals were sacrificed seven days after MTX administration for tissue sampling.
Co-administration of growth hormone and a hyperproteic diet increased intestinal crypt proliferation and reduced MTX-induced apoptosis.
Jejunal mucosal structure (morphometry), proliferation (Ki-67) and apoptosis (TUNNEL) were assessed.